A Comparative Study of Preemptive External Oblique Plane Block and Subcostal TAP Block for Postoperative Analgesia in Radical Cholecystectomy: A Randomised Single-Blinded Prospective Study
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
- 试验地点
- 1
研究概览
简要总结
Radical cholecystectomy is the standard surgical treatment for gallbladder carcinoma, involving extensive dissection, subcostal incisions, and lymphadenectomy. This results in significant somatic and visceral pain, posing challenges for optimal postoperative analgesia.”
In oncoanesthesia, effective pain control is vital not only for comfort but also to reduce complications, facilitate early recovery, and support immune function.
Systemic opioids have traditionally been the mainstay for analgesia but are associated with several drawbacks: respiratory depression, ileus, sedation, delayed mobilization, opioid tolerance, and immunosuppression—all particularly concerning in cancer patients. Hence, modern cancer care emphasizes opioid-sparing
Ultrasound-guided regional blocks have emerged as safer and more targeted alternatives.
The subcostal TAP block, targeting T6–T9 nerves, provides anterior abdominal wall analgesia but lacks visceral coverage and has limited lateral spread. In contrast, the External Oblique Plane (EOP) block—a newer technique—targets T6–T12 lateral cutaneous branches, potentially offering broader dermatomal coverage. Its superficial location aids visualization and makes it safer in coagulopathic or anatomically altered patients—common scenarios in oncoanesthesia.
Importantly, preemptive administration of these blocks can reduce central sensitization, lower opioid needs, and enhance recovery—core principles of Enhanced Recovery After Surgery (ERAS) in oncology. However, comparative data on EOP versus subcostal TAP blocks in radical cholecystectomy are scarce.
This randomized, single-blinded prospective study aims to compare the analgesic efficacy, opioid-sparing effect, safety, and patient satisfaction of preemptive EOP and subcostal TAP blocks with 0.2% ropivacaine in radical cholecystectomy
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Investigator Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients aged 18 to 65 years ASA physical status I or II Scheduled for elective radical cholecystectomy for gallbladder carcinoma Ability to provide written informed consent.
排除标准
- •Known allergy or hypersensitivity to amide local anaesthetics Local infection at the block site Coagulopathy BMI more than 35 Chronic opioid use or history of substance use disorder Cognitive impairment or communication barriers.
研究者
Trishagni Talukdar
State Cancer Institute
